Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 1Pharmathen SA
02 1Ajanta Pharma Limited
03 1Apotex Pharmachem
04 1Aurobindo Pharma Limited
05 1Aurore Life Sciences
06 1Calyx Chemicals & Pharmaceuticals Limited
07 3Charioteer
08 1Cipla
09 1CordenPharma
10 1Hetero Drugs
11 1Maithri Drugs
12 4Olon S.p.A
13 2RANBAXY LABORATORIES LIMITED
14 1Shanghai Pharma Group
15 2Viatris
01 1VALGANCICLOVIR HCL AMORPHOUS TYPE II
02 1VALGANCICLOVIR HCL CRYSTALLINE TYPE II
03 5VALGANCICLOVIR HYDROCHLORIDE
04 1VALGANCICLOVIR HYDROCHLORIDE (NON-STERILE BULK)
05 1VALGANCICLOVIR HYDROCHLORIDE AMORPHOUS
06 1VALGANCICLOVIR HYDROCHLORIDE CRYSTALLINE
07 4VALGANCICLOVIR HYDROCHLORIDE USP
08 1VALGANCICLOVIR HYDROCHLORIDE USP (CRYSTALLINE)
09 1VALGANCICLOVIR HYDROCHLORIDE USP (CRYSTALLINE) FORM A
10 1VALGANCICLOVIR HYDROCHLORIDE USP (Crystalline)
11 1VALGANCICLOVIR HYDROCHLORIDE USP (NON-STERILE DRUG SUBSTANCE)
12 1VALGANCICLOVIR HYDROCHLORIDE, AMORPHOUS (DRUG SUBSTANCE)
13 1VALGANCICLOVIR HYDROCHLORIDE, CRYSTALLINE (DRUG SUBSTANCE)
14 1VALGANCICLOVIR HYDROCHLORIDE, USP
15 1VALGANCICLOVIR HYDROCHLORIDE, USP (PROCESS 2; SITE TOANSA)
01 1Canada
02 4China
03 1Germany
04 1Greece
05 9India
06 4Italy
07 2U.S.A
01 17Active
02 5Inactive
01 13Complete
02 9Blank
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
GDUFA
DMF Review : Complete
Rev. Date : 2017-11-07
Pay. Date : 2017-04-28
DMF Number : 31546
Submission : 2017-05-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-16
Pay. Date : 2015-11-10
DMF Number : 26314
Submission : 2012-08-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26889
Submission : 2012-11-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-01
Pay. Date : 2015-09-29
DMF Number : 28360
Submission : 2014-06-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30023
Submission : 2015-11-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-28
Pay. Date : 2012-12-07
DMF Number : 26079
Submission : 2012-05-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-05
Pay. Date : 2018-06-22
DMF Number : 32488
Submission : 2018-06-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-09
Pay. Date : 2012-12-21
DMF Number : 23044
Submission : 2009-08-04
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-06
Pay. Date : 2012-11-06
DMF Number : 23859
Submission : 2010-05-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-04
Pay. Date : 2015-09-28
DMF Number : 23322
Submission : 2009-11-30
Status : Active
Type : II
A Valganciclovir Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valganciclovir Hydrochloride, including repackagers and relabelers. The FDA regulates Valganciclovir Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valganciclovir Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valganciclovir Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valganciclovir Hydrochloride supplier is an individual or a company that provides Valganciclovir Hydrochloride active pharmaceutical ingredient (API) or Valganciclovir Hydrochloride finished formulations upon request. The Valganciclovir Hydrochloride suppliers may include Valganciclovir Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Valganciclovir Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Valganciclovir Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Valganciclovir Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Valganciclovir Hydrochloride DMFs exist exist since differing nations have different regulations, such as Valganciclovir Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Valganciclovir Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Valganciclovir Hydrochloride USDMF includes data on Valganciclovir Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Valganciclovir Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Valganciclovir Hydrochloride suppliers with USDMF on PharmaCompass.
We have 15 companies offering Valganciclovir Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?